Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 50.82 is 499% above its 5-year average of 8.49, near the high end of its 5-year range (4.75–50.82).
As of the fiscal period ended Tuesday, June 30, 2026. 134.97% above its 12-month average of 21.63.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 50.82.
QUICK RATIO (ACID-TEST)
50.82
QUICK RATIO (ACID-TEST) AVG TTM
21.63
QUICK RATIO (ACID-TEST) AVG 3Y
7.27
QUICK RATIO (ACID-TEST) AVG 5Y
8.49
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+134.97%
CURRENT VS 3Y AVG
+599.57%
CURRENT VS 5Y AVG
+498.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+1414.87%
vs the sector median at left
Tango Therapeutics, Inc.
Market Cap
$3.57B
Quick Ratio (Acid-Test)
50.82
TTM Avg
21.63
3Y Avg
7.27
5Y Avg
8.49
Market Cap
$3.54B
Quick Ratio (Acid-Test)
21.02
TTM Avg
15.64
3Y Avg
20.34
5Y Avg
22.11
Market Cap
$3.52B
Quick Ratio (Acid-Test)
3.75
TTM Avg
5.09
3Y Avg
3.82
5Y Avg
4.05
Market Cap
$3.64B
Quick Ratio (Acid-Test)
1.42
TTM Avg
24.66
3Y Avg
24.27
5Y Avg
16.20
Market Cap
$3.48B
Quick Ratio (Acid-Test)
10.45
TTM Avg
13.16
3Y Avg
14.41
5Y Avg
11.78
Market Cap
$3.47B
Quick Ratio (Acid-Test)
8.93
TTM Avg
9.13
3Y Avg
14.29
5Y Avg
16.91
Market Cap
$3.44B
Quick Ratio (Acid-Test)
9.61
TTM Avg
11.20
3Y Avg
9.88
5Y Avg
7.68
Market Cap
$3.38B
Quick Ratio (Acid-Test)
3.30
TTM Avg
3.01
3Y Avg
3.08
5Y Avg
4.22
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tango Therapeutics, Inc. (TNGX) | $3.57B | 50.82 | 21.63 | 7.27 | 8.49 |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 8.80 | 6.13 | 5.10 | 7.69 |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | 21.02 | 15.64 | 20.34 | 22.11 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | 3.75 | 5.09 | 3.82 | 4.05 |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.64B | 1.42 | 24.66 | 24.27 | 16.20 |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | 10.45 | 13.16 | 14.41 | 11.78 |
| Celcuity Inc. (CELC)vs › | $3.47B | 8.93 | 9.13 | 14.29 | 16.91 |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | 9.61 | 11.20 | 9.88 | 7.68 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 3.30 | 3.01 | 3.08 | 4.22 |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | 17.91 | 1.68 | 1.68 | 1.68 |
Quick Ratio
50.82
Excludes inventory
Current Ratio
50.82
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 50.82 |
| 2026-03-31 | 27.38 |
| 2025-12-31 | 16.32 |
| 2025-09-30 | 8.88 |
| 2025-06-30 | 4.75 |
| 2025-03-31 | 6.26 |
| 2024-12-31 | 6.98 |
| 2024-09-30 | 8.00 |
| 2024-06-30 | 7.49 |
| 2024-03-31 | 8.23 |
| 2023-12-31 | 7.54 |
| 2023-09-30 | 8.54 |
| 2023-06-30 | 5.98 |
| 2023-03-31 | 6.39 |
| 2022-12-31 | 6.76 |
| 2022-09-30 | 7.83 |
| 2022-06-30 | 9.76 |
| 2022-03-31 | 11.75 |
| 2021-12-31 | 12.10 |
| 2021-09-30 | 12.30 |
| 2021-06-30 | 5.43 |
| 2021-03-31 | 5.71 |
| 2020-12-31 | 4.73 |
| 2020-09-30 | 14.10 |
| 2020-06-30 | 0.64 |
| 2020-03-31 | 0.00 |
